Plasma amine oxidase: A postulated cardiovascular risk factor in nondiabetic obese patients

Metabolism: Clinical and Experimental

Volumn 52, Issue 6, 2003, Pages 688-692

  Weiss, H G ^a   Klocker, J ^a   Labeck, B ^a   Nehoda, H ^a   Aigner, F ^a   Klingler, A ^a   Ebenbichler, C ^a   Foger B ^a   Lechleitner, M ^a   Patsch, J R ^a   Schwelberger, H G ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); C PEPTIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEMICARBAZIDE SENSITIVE PLASMA AMINE OXIDASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOTHELIUM INJURY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LABORATORY TEST; LIPID METABOLISM; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOMETRY; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; GLUCOSE INTOLERANCE; MORBID OBESITY; PATHOPHYSIOLOGY;

ADULT; AMINE OXIDASE (COPPER-CONTAINING); CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; OBESITY, MORBID; RISK FACTORS;

EID: 0037804660     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00028-3     Document Type: Article

References (29)

1. Spiegelman BM, Flier JS: Adipogenesis and obesity: Rounding out the big picture. Cell 87:377-389, 1996
2. World Health Organization: Obesity. Preventing and Managing the Global Epidemic. Report of a WHO consultation on obesity. Geneva, Switzerland, World Health Organization, 1997
3. Larsson B, Björntop P, Tibblin G: The health consequence of moderate obesity. Int J Obes 5:97-116, 1981
4. Dyer AR, Elliott P: The INTERSALT study: Relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens 3:299-308, 1989
5. Eckel R, Krauss R: American Heart Association calls to action: Obesity as a major risk factor for coronary heart disease. Circulation 97:2099-2100, 1998
6. Stevens J, Cai J, Pamuk ER, et al: The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1-7, 1998
7. 2 or products of activated neutrophils. Am J Med 91:89S-94S, 1991
8. Bouloimie A, Marumo T, Lafontan M, et al: Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231-1238, 1999
9. Lyles GA: Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: Biochemical, pharmacological, and toxicological aspects. Int J Biochem Cell Biol 28:259-274, 1996
10. McEwen CM: Human plasma monoamine oxidase. I. Purification and identification. J Biol Chem 240:2003-2010, 1965
11. Ekblom J: Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: Vascular cytoprotection in diabetes mellitus. Pharmacol Res 37:87-92, 1998
12. Yu PH, Zuo DM: Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells: Possible consequences for diabetes. Diabetes 42:594-603, 1993
13. Yu PH, Zuo DM: Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atheriosclerosis 120:189-197, 1996
14. Yu PH, Lai CT, Zuo DM: Formation of formaldehyde from adrenaline in vivo: A potential risk factor for stress-related angiopathy. Neurochem Res 22:615-620, 1997
15. Boomsma F, Derkx FHM, Van Den Meiracker AH, et al: Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci 88:675-679, 1995
16. Meszaros Z, Szombathy T, Raimondi L, et al: Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: Correlation with body mass index and serum triglyceride. Metabolism 48:113-117, 1999
17. Lizcano JM, Tipton KF, Unzeta M: Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. Biochem J 331:69-78, 1998
18. Patsch W, Brown SA, Morrisett J, et al: A dual precipitation method evaluated for measurement of cholesterol in high-density lipoprotein HDL2 and HDL3 in human plasma. Clin Chem 35:265-270, 1989
19. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-501, 1972
20. Morris NJ, Ducret A, Aebersold R, et al: Membrane amine oxidase cloning and identification as a major protein in the adipocyte plasma membrane. J Biol Chem 272:9388-9392, 1997
21. Salmi M, Jalkanen S: A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257:1407-1409, 1992
22. Bono P, Salmi M, Smith DJ, et al: Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J Immunol 160:5563-5571, 1998
23. Smith DJ, Salmi M, Bono P, et al: Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 188:17-27, 1998
24. Kurkijärvi R, Adams DH, Leino R, et al: Circulating form of human vascular adhesion protein-1 (VAP-1): Increased serum levels in inflammatory liver diseases. J Immunol 161:1549-1557, 1998
25. Kurkijärvi R, Yegutkin GG, Gunson BK, et al: Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 119:1096-1103, 2000
26. Moldes M, Féve B, Pairault J: Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage. J Biol Chem 274:9515-9523, 1999
27. Yu PH, Zuo DM: Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: Implications for advanced glycation and diabetic complications. Diabetologia 40:1243-1250, 1997
28. Salmi M, Jalkanen S: VAP-1: An adhesin and an enzyme. Trends Immunol 4:211-216, 2001
29. Buffoni F: Histaminase and related amine oxidases. Pharmacol Rev 18:1163-1199, 1966